Estrogen Therapy in Turner's Syndrome
- 1 April 1992
- journal article
- review article
- Published by Wiley in Pediatrics International
- Vol. 34 (2) , 195-205
- https://doi.org/10.1111/j.1442-200x.1992.tb00950.x
Abstract
Girls with Turner's sydrome are born short, grow slowly, and usually fail to enter puberty spontaneously and to undergo a pubertal growth spurt. The goal of estrogen therapy is to correct estrogen deficiency in a manner that optimizes height potential, permits attainment of normal bone mass, and provides appropriate feminization with minimal risk of adverse effects. The issues to be resolved include the age at which treatment should be begun, the preparation, route of administration, and dosage to be given, the effect on concurrent growth hormone administration, the rate of dose increase during treatment, the timing and nature of progestin administration, and the total duration of treatment. The available data suggest that treatment should be initiated between the ages of 12 and 14 years. The dose‐response relationship between growth rate and estrogen dose is biphasic. Optimal growth stimulation for ethinyl estradiol occurs at approximately 100 ng/kg body weight per day, which is below the dose that produces full feminization. Although suboptimal doses of estrogen and growth hormone appear to have additive effects, estrogen causes only a minor increase in the short‐term growth response to an optimal dose of growth hormone. The long‐term effects of estrogen combined with growth hormone are unknown. In the absence of data concerning the outcome of different dose schedules, we treat for 2 years at 100 ng/kg/day of ethinyl estradiol, then double the dose annually until menstruation, at which time cyclic monthly progestin therapy is added (medroxyprogesterone acetate 10 mg daily from days 16 to 25). The importance of estrogen in maintaining normal bone mass suggests that treatment should be lifelong. Current research in our clinic is assessing the long‐term effect on adult height of ultra‐low‐dose treatment (25 to 50 ng/kg/day of ethinyl estradiol) during the childhood years (ages 5 to 11), alone or in conjunction with supplemental growth hormone.Keywords
This publication has 28 references indexed in Scilit:
- Turner Syndrome: Effect of Hormone Therapies on Height Velocity and Adult HeightActa Paediatrica, 1988
- Current Views on the Treatment of Turner's SyndromeActa Paediatrica, 1987
- Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndromeThe Journal of Pediatrics, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Growth curve for girls with Turner syndrome.Archives of Disease in Childhood, 1985
- Adult height in Turner syndrome with and without androgen therapyThe Journal of Pediatrics, 1984
- A Preliminary Study of the Effect of Estrogen Dose on Growth in Turner's SyndromeNew England Journal of Medicine, 1983
- Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various patholgoic conditionsThe Journal of Pediatrics, 1978
- Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient childrenThe Journal of Pediatrics, 1976
- The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agersThe Journal of Pediatrics, 1974